107 related articles for article (PubMed ID: 3790154)
1. Effects of cis-diamminedichloroplatinum on DNA incorporation and cytotoxicity of 1-beta-D-arabinofuranosylcytosine.
Spriggs DR; Robbins G; Kufe DW
Biochem Pharmacol; 1986 Dec; 35(23):4297-302. PubMed ID: 3790154
[TBL] [Abstract][Full Text] [Related]
2. Interactions of cis-diamminedichloroplatinum(II) with 1-beta-D-arabinofuranosylcytosine in LoVo colon carcinoma cells.
Fram RJ; Robichaud N; Bishov SD; Wilson JM
Cancer Res; 1987 Jul; 47(13):3360-5. PubMed ID: 3107809
[TBL] [Abstract][Full Text] [Related]
3. Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
Kufe DW; Weichselbaum R; Egan EM; Dahlberg W; Fram RJ
Mol Pharmacol; 1984 Mar; 25(2):322-6. PubMed ID: 6700578
[TBL] [Abstract][Full Text] [Related]
4. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC
Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295
[TBL] [Abstract][Full Text] [Related]
5. Synergism of 1-beta-D-arabinofuranosylcytosine and cis-diamminedichloroplatinum in their lethal efficacies against seven established cancer cell lines of gastrointestinal origin.
Trujillo JM; Yang LY
Anticancer Res; 1989; 9(1):197-201. PubMed ID: 2705747
[TBL] [Abstract][Full Text] [Related]
6. In vitro pharmacodynamics of 1-beta-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II).
Kern DH; Morgan CR; Hildebrand-Zanki SU
Cancer Res; 1988 Jan; 48(1):117-21. PubMed ID: 3334986
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
Vadi H; Drewinko B
Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
[TBL] [Abstract][Full Text] [Related]
8. Correlation of cytotoxicity with incorporation of ara-C into DNA.
Kufe DW; Major PP; Egan EM; Beardsley GP
J Biol Chem; 1980 Oct; 255(19):8997-900. PubMed ID: 7410404
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of ara-C induced cytotoxicity by hydroxyurea in LoVo colon carcinoma cells.
Robichaud NJ; Fram RJ
Biochem Pharmacol; 1987 May; 36(10):1673-7. PubMed ID: 3109427
[TBL] [Abstract][Full Text] [Related]
10. Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.
Major PP; Egan EM; Beardsley GP; Minden MD; Kufe DW
Proc Natl Acad Sci U S A; 1981 May; 78(5):3235-9. PubMed ID: 6942429
[TBL] [Abstract][Full Text] [Related]
11. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
Yang LY; Li L; Keating MJ; Plunkett W
Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
[TBL] [Abstract][Full Text] [Related]
12. Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cells.
Kufe D; Spriggs D; Egan EM; Munroe D
Blood; 1984 Jul; 64(1):54-8. PubMed ID: 6587917
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
Grem JL; Allegra CJ
Cancer Res; 1990 Nov; 50(22):7279-84. PubMed ID: 1699659
[TBL] [Abstract][Full Text] [Related]
14. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine.
Grem JL; Allegra CJ
Biochem Pharmacol; 1991 Jul; 42(2):409-18. PubMed ID: 1713459
[TBL] [Abstract][Full Text] [Related]
15. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D
Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261
[TBL] [Abstract][Full Text] [Related]
16. Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinum.
Trujillo JM; Yang LY; Gercovich G; Su YZ; Lee J
Anticancer Res; 1989; 9(6):1751-6. PubMed ID: 2627125
[TBL] [Abstract][Full Text] [Related]
17. Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells.
Ross DD; Joneckis CC; Song TH; Wu RK
Cancer Res; 1988 Feb; 48(3):517-21. PubMed ID: 3335018
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system.
Kishi S; Goto N; Nakamura T; Ueda T
Cancer Res; 1999 Jun; 59(11):2629-34. PubMed ID: 10363985
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
Kufe D; Herrick D; Crumpacker C; Schnipper L
Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
Swinnen LJ; Ellis NK; Erickson LC
Cancer Res; 1991 Apr; 51(8):1984-9. PubMed ID: 2009517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
